In the previously reported cases, MSH3 pathogenic variants led to the complete loss of MSH3 protein from normal colonocytes and tumor cells, resulting in elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in tumor tissues1. This evidence concerns the gene MSH3 and neoplasm.